Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1

被引:319
作者
Stanley, SK
Ostrowski, MA
Justement, JS
Gantt, K
Hedayati, S
Mannix, M
Roche, K
Schwartzentruber, DJ
Fox, CH
Fauci, AS
机构
[1] NCI,DEPT NURSING,WARREN GRANT MAGNUSON CLIN CTR,BETHESDA,MD 20892
[2] NCI,DIV CANC TREATMENT,BETHESDA,MD 20892
[3] MOL HISTOL INC,GAITHERSBURG,MD
关键词
D O I
10.1056/NEJM199605093341903
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Activation of the immune system is a normal response to antigenic stimulation, and such activation enhances the replication of human immunodeficiency virus type 1 (HIV-1). We studied the effect of immunization with a common recall antigen on viral expression in HIV-1-infected patients, on the ability to isolate virus, and on the susceptibility to HIV-1 infection of peripheral-blood mononuclear cells (PBMCs) from control subjects not infected with HIV-1. Methods. Thirteen HIV-1-infected patients and 10 uninfected adults were given a 0.5-ml booster dose of tetanus toroid. Studies were performed to evaluate changes in the degree of plasma viremia, proviral burden, the ability to isolate HIV-1, and the susceptibility of PBMCs to acute infection in vitro. Two patients underwent sequential lymph-node biopsies for the assessment of viral burden in these tissues. Results. All 13 HIV-1-infected patients had transient increases in plasma viremia after immunization, and the proviral burden increased in 11. These changes did not correlate with the base-line CD4+ T-cell counts. The lymph-node tissue also had increases in the proviral burden and viral RNA after immunization. The virus was more easily isolated from PBMCs from nine of the patients after immunization than before immunization. Despite considerable variability in the results, PBMCs from 7 of the 10 normal subjects were more easily infected in vitro with HIV-1 after immunization than before immunization. Conclusions. Activation of the immune system by an ongoing antigen-specific immune response to an exogenous stimulus transiently increases the expression of HIV-1 and may enhance the susceptibility of uninfected subjects to HIV-1. (C) 1996, Massachusetts Medical Society.
引用
收藏
页码:1222 / 1230
页数:9
相关论文
共 31 条
  • [1] IMMUNE ACTIVATION IS A DOMINANT FACTOR IN THE PATHOGENESIS OF AFRICAN AIDS
    BENTWICH, Z
    KALINKOVICH, A
    WEISMAN, Z
    [J]. IMMUNOLOGY TODAY, 1995, 16 (04): : 187 - 191
  • [2] BRICHACEK B, 1995, 2 NAT C HUM RETR REL, P98
  • [3] QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION
    BUKRINSKY, MI
    STANWICK, TL
    DEMPSEY, MP
    STEVENSON, M
    [J]. SCIENCE, 1991, 254 (5030) : 423 - 427
  • [4] SYSTEMIC LYMPHADENOPATHIC HISTOLOGY IN HUMAN IMMUNODEFICIENCY VIRUS-1-SEROPOSITIVE DRUG-ADDICTS WITHOUT APPARENT ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BURKE, AP
    ANDERSON, D
    MANNAN, P
    RIBAS, JL
    LIANG, YH
    SMIALEK, J
    VIRMANI, R
    [J]. HUMAN PATHOLOGY, 1994, 25 (03) : 248 - 256
  • [5] TRANSIENT ELEVATION OF SERUM HIV ANTIGEN LEVELS ASSOCIATED WITH INTERCURRENT INFECTION
    CLAYDON, EJ
    BENNETT, J
    GOR, D
    FORSTER, SM
    [J]. AIDS, 1991, 5 (01) : 113 - 114
  • [6] DECREASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PLASMA VIREMIA DURING ANTIRETROVIRAL THERAPY REFLECTS DOWN-REGULATION OF VIRAL REPLICATION IN LYMPHOID-TISSUE
    COHEN, OJ
    PANTALEO, G
    HOLODNIY, M
    SCHNITMAN, S
    NIU, M
    GRAZIOSI, C
    PAVLAKIS, GN
    LALEZARI, J
    BARTLETT, JA
    STEIGBIGEL, RT
    COHN, J
    NOVAK, R
    MCMAHON, D
    FAUCI, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) : 6017 - 6021
  • [7] COLEBUNDERS RL, 1991, AIDS, V5, pS103
  • [8] MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS
    EMBRETSON, J
    ZUPANCIC, M
    RIBAS, JL
    BURKE, A
    RACZ, P
    TENNERRACZ, K
    HAASE, AT
    [J]. NATURE, 1993, 362 (6418) : 359 - 362
  • [9] MULTIFACTORIAL NATURE OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - IMPLICATIONS FOR THERAPY
    FAUCI, AS
    [J]. SCIENCE, 1993, 262 (5136) : 1011 - 1018
  • [10] FOLKS T, 1986, J IMMUNOL, V136, P4049